Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Published:2020-05 Issue:5 Volume:21 Page:655-663
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Goldberg Sarah B,Schalper Kurt A,Gettinger Scott N,Mahajan Amit,Herbst Roy S,Chiang Anne C,Lilenbaum Rogerio,Wilson Frederick H,Omay Sacit Bulent,Yu James B,Jilaveanu Lucia,Tran Thuy,Pavlik Kira,Rowen Elin,Gerrish Heather,Komlo Annette,Gupta Richa,Wyatt Hailey,Ribeiro Matthew,Kluger Yuval,Zhou Geyu,Wei Wei,Chiang Veronica L,Kluger Harriet M

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Non-small-cell lung cancer with brain metastasis at presentation;Waqar;Clin Lung Cancer,2018

2. The evolving landscape of brain metastasis;Valiente;Trends Cancer,2018

3. CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer;Reungwetwattana;J Clin Oncol,2018

4. Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study;Gadgeel;Ann Oncol,2018

5. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

Cited by 376 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Perspective Chapter: Targeting the Myeloid Compartment – Innovative Immunotherapy Strategies for Malignant Brain Tumors;Advanced Concepts and Strategies in Central Nervous System Tumors [Working Title];2024-09-13

3. Development of brain metastases in non-small-cell lung cancer: high-risk features;CNS Oncology;2024-09-12

4. Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature;Cancers;2024-09-08

5. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024